Marvelon and cyanosis Patient Reports February 12, 2012

Marvelon Side Effects Report #6060097-2
Marvelon side effect was reported by a Consumer or non-health professional from FRANCE on Jan 15, 2009. Female patient, 32 years of age, was diagnosed with contraception and was treated with Marvelon. After drug was administered, patient experienced the following side effects: axillary vein thrombosis, cyanosis, subclavian vein thrombosis, thrombophlebitis superficial. Marvelon dosage: unknown. During the same period patient was treated with SOTALOL. Patient was hospitalized. Patient recovered.

Marvelon Side Effects Report #6060103-5
Marvelon side effect was reported by a Consumer or non-health professional from FRANCE on Jan 15, 2009. Female patient, 32 years of age, was diagnosed with contraception and was treated with Marvelon. After drug was administered, patient experienced the following side effects: axillary vein thrombosis, cyanosis, subclavian vein thrombosis, thrombophlebitis superficial. Marvelon dosage: unknown. During the same period patient was treated with SOTALOL. Patient was hospitalized. Patient recovered.

Marvelon Side Effects Report #5258232-9
Marvelon side effect was reported by a Consumer or non-health professional from DENMARK on Feb 27, 2007. Female patient, 27 years of age, was diagnosed with contraception and was treated with Marvelon. After drug was administered, patient experienced the following side effects: androgens abnormal, cardiac arrest , cold sweat, cyanosis, deep vein thrombosis , dehydration, hypotension, musculoskeletal chest pain, palpitations. Marvelon dosage: unknown. Patient died.

Marvelon Side Effects Report #5317828-6
Marvelon side effect was reported by a Consumer or non-health professional from DENMARK on Apr 24, 2007. Female patient, 27 years of age, was diagnosed with contraception and was treated with Marvelon. After drug was administered, patient experienced the following side effects: cardiac arrest , cold sweat, cyanosis, deep vein thrombosis , dehydration, gait disturbance, hypotension, musculoskeletal chest pain, palpitations. Marvelon dosage: unknown. Patient died.